- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Pre-Menstrual Syndrome market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Pre-Menstrual Syndrome market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Pre-Menstrual Syndrome global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Analgesics (Pain Killers) segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Pre-Menstrual Syndrome include Alva-Amco Pharmacal Cos., Inc., Bayer, Inc., Chattem, Inc. (Sanofi), DEKK-TEC, Inc., and G. R. Lane Health Products Ltd, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Pre-Menstrual Syndrome market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Analgesics (Pain Killers)
Oral Contraceptive Pills (OCPs)
Gonadotropin-Releasing Hormone (GnRH)
Antidepressants
Ovarian Suppressors
Diuretics
Benzodiazepines
Market segment by Application, can be divided into
Hospitals
Clinic
Others
Market segment by players, this report covers
Alva-Amco Pharmacal Cos., Inc.
Bayer, Inc.
Chattem, Inc. (Sanofi)
DEKK-TEC, Inc.
G. R. Lane Health Products Ltd
McNeil Consumer Healthcare
MetP Pharma AG
Pherin Pharmaceuticals, Inc.
Umecrine Mood AB
Novartis AG
GlaxoSmithKline Plc
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Pre-Menstrual Syndrome product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Pre-Menstrual Syndrome, with revenue, gross margin and global market share of Pre-Menstrual Syndrome from 2019 to 2022.
Chapter 3, the Pre-Menstrual Syndrome competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Pre-Menstrual Syndrome market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Pre-Menstrual Syndrome research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1 Market Overview
1.1 Product Overview and Scope of Pre-Menstrual Syndrome
1.2 Classification of Pre-Menstrual Syndrome by Type
1.2.1 Overview: Global Pre-Menstrual Syndrome Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Pre-Menstrual Syndrome Revenue Market Share by Type in 2021
1.2.3 Analgesics (Pain Killers)
1.2.4 Oral Contraceptive Pills (OCPs)
1.2.5 Gonadotropin-Releasing Hormone (GnRH)
1.2.6 Antidepressants
1.2.7 Ovarian Suppressors
1.2.8 Diuretics
1.2.9 Benzodiazepines
1.3 Global Pre-Menstrual Syndrome Market by Application
1.3.1 Overview: Global Pre-Menstrual Syndrome Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Global Pre-Menstrual Syndrome Market Size & Forecast
1.5 Global Pre-Menstrual Syndrome Market Size and Forecast by Region
1.5.1 Global Pre-Menstrual Syndrome Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Pre-Menstrual Syndrome Market Size by Region, (2017-2022)
1.5.3 North America Pre-Menstrual Syndrome Market Size and Prospect (2017-2028)
1.5.4 Europe Pre-Menstrual Syndrome Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Pre-Menstrual Syndrome Market Size and Prospect (2017-2028)
1.5.6 South America Pre-Menstrual Syndrome Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Pre-Menstrual Syndrome Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Pre-Menstrual Syndrome Market Drivers
1.6.2 Pre-Menstrual Syndrome Market Restraints
1.6.3 Pre-Menstrual Syndrome Trends Analysis
2 Company Profiles
2 Company Profiles
2.1 Alva-Amco Pharmacal Cos., Inc.
2.1.1 Alva-Amco Pharmacal Cos., Inc. Details
2.1.2 Alva-Amco Pharmacal Cos., Inc. Major Business
2.1.3 Alva-Amco Pharmacal Cos., Inc. Pre-Menstrual Syndrome Product and Solutions
2.1.4 Alva-Amco Pharmacal Cos., Inc. Pre-Menstrual Syndrome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Alva-Amco Pharmacal Cos., Inc. Recent Developments and Future Plans
2.2 Bayer, Inc.
2.2.1 Bayer, Inc. Details
2.2.2 Bayer, Inc. Major Business
2.2.3 Bayer, Inc. Pre-Menstrual Syndrome Product and Solutions
2.2.4 Bayer, Inc. Pre-Menstrual Syndrome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Bayer, Inc. Recent Developments and Future Plans
2.3 Chattem, Inc. (Sanofi)
2.3.1 Chattem, Inc. (Sanofi) Details
2.3.2 Chattem, Inc. (Sanofi) Major Business
2.3.3 Chattem, Inc. (Sanofi) Pre-Menstrual Syndrome Product and Solutions
2.3.4 Chattem, Inc. (Sanofi) Pre-Menstrual Syndrome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Chattem, Inc. (Sanofi) Recent Developments and Future Plans
2.4 DEKK-TEC, Inc.
2.4.1 DEKK-TEC, Inc. Details
2.4.2 DEKK-TEC, Inc. Major Business
2.4.3 DEKK-TEC, Inc. Pre-Menstrual Syndrome Product and Solutions
2.4.4 DEKK-TEC, Inc. Pre-Menstrual Syndrome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 DEKK-TEC, Inc. Recent Developments and Future Plans
2.5 G. R. Lane Health Products Ltd
2.5.1 G. R. Lane Health Products Ltd Details
2.5.2 G. R. Lane Health Products Ltd Major Business
2.5.3 G. R. Lane Health Products Ltd Pre-Menstrual Syndrome Product and Solutions
2.5.4 G. R. Lane Health Products Ltd Pre-Menstrual Syndrome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 G. R. Lane Health Products Ltd Recent Developments and Future Plans
2.6 McNeil Consumer Healthcare
2.6.1 McNeil Consumer Healthcare Details
2.6.2 McNeil Consumer Healthcare Major Business
2.6.3 McNeil Consumer Healthcare Pre-Menstrual Syndrome Product and Solutions
2.6.4 McNeil Consumer Healthcare Pre-Menstrual Syndrome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 McNeil Consumer Healthcare Recent Developments and Future Plans
2.7 MetP Pharma AG
2.7.1 MetP Pharma AG Details
2.7.2 MetP Pharma AG Major Business
2.7.3 MetP Pharma AG Pre-Menstrual Syndrome Product and Solutions
2.7.4 MetP Pharma AG Pre-Menstrual Syndrome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 MetP Pharma AG Recent Developments and Future Plans
2.8 Pherin Pharmaceuticals, Inc.
2.8.1 Pherin Pharmaceuticals, Inc. Details
2.8.2 Pherin Pharmaceuticals, Inc. Major Business
2.8.3 Pherin Pharmaceuticals, Inc. Pre-Menstrual Syndrome Product and Solutions
2.8.4 Pherin Pharmaceuticals, Inc. Pre-Menstrual Syndrome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Pherin Pharmaceuticals, Inc. Recent Developments and Future Plans
2.9 Umecrine Mood AB
2.9.1 Umecrine Mood AB Details
2.9.2 Umecrine Mood AB Major Business
2.9.3 Umecrine Mood AB Pre-Menstrual Syndrome Product and Solutions
2.9.4 Umecrine Mood AB Pre-Menstrual Syndrome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Umecrine Mood AB Recent Developments and Future Plans
2.10 Novartis AG
2.10.1 Novartis AG Details
2.10.2 Novartis AG Major Business
2.10.3 Novartis AG Pre-Menstrual Syndrome Product and Solutions
2.10.4 Novartis AG Pre-Menstrual Syndrome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Novartis AG Recent Developments and Future Plans
2.11 GlaxoSmithKline Plc
2.11.1 GlaxoSmithKline Plc Details
2.11.2 GlaxoSmithKline Plc Major Business
2.11.3 GlaxoSmithKline Plc Pre-Menstrual Syndrome Product and Solutions
2.11.4 GlaxoSmithKline Plc Pre-Menstrual Syndrome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 GlaxoSmithKline Plc Recent Developments and Future Plans
3 Market Competition, by Players
3 Market Competition, by Players
3.1 Global Pre-Menstrual Syndrome Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Pre-Menstrual Syndrome Players Market Share in 2021
3.2.2 Top 10 Pre-Menstrual Syndrome Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Pre-Menstrual Syndrome Players Head Office, Products and Services Provided
3.4 Pre-Menstrual Syndrome Mergers & Acquisitions
3.5 Pre-Menstrual Syndrome New Entrants and Expansion Plans
4 Market Size Segment by Type
4 Market Size Segment by Type
4.1 Global Pre-Menstrual Syndrome Revenue and Market Share by Type (2017-2022)
4.2 Global Pre-Menstrual Syndrome Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5 Market Size Segment by Application
5.1 Global Pre-Menstrual Syndrome Revenue Market Share by Application (2017-2022)
5.2 Global Pre-Menstrual Syndrome Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6 North America by Country, by Type, and by Application
6.1 North America Pre-Menstrual Syndrome Revenue by Type (2017-2028)
6.2 North America Pre-Menstrual Syndrome Revenue by Application (2017-2028)
6.3 North America Pre-Menstrual Syndrome Market Size by Country
6.3.1 North America Pre-Menstrual Syndrome Revenue by Country (2017-2028)
6.3.2 United States Pre-Menstrual Syndrome Market Size and Forecast (2017-2028)
6.3.3 Canada Pre-Menstrual Syndrome Market Size and Forecast (2017-2028)
6.3.4 Mexico Pre-Menstrual Syndrome Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7 Europe by Country, by Type, and by Application
7.1 Europe Pre-Menstrual Syndrome Revenue by Type (2017-2028)
7.2 Europe Pre-Menstrual Syndrome Revenue by Application (2017-2028)
7.3 Europe Pre-Menstrual Syndrome Market Size by Country
7.3.1 Europe Pre-Menstrual Syndrome Revenue by Country (2017-2028)
7.3.2 Germany Pre-Menstrual Syndrome Market Size and Forecast (2017-2028)
7.3.3 France Pre-Menstrual Syndrome Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Pre-Menstrual Syndrome Market Size and Forecast (2017-2028)
7.3.5 Russia Pre-Menstrual Syndrome Market Size and Forecast (2017-2028)
7.3.6 Italy Pre-Menstrual Syndrome Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Pre-Menstrual Syndrome Revenue by Type (2017-2028)
8.2 Asia-Pacific Pre-Menstrual Syndrome Revenue by Application (2017-2028)
8.3 Asia-Pacific Pre-Menstrual Syndrome Market Size by Region
8.3.1 Asia-Pacific Pre-Menstrual Syndrome Revenue by Region (2017-2028)
8.3.2 China Pre-Menstrual Syndrome Market Size and Forecast (2017-2028)
8.3.3 Japan Pre-Menstrual Syndrome Market Size and Forecast (2017-2028)
8.3.4 South Korea Pre-Menstrual Syndrome Market Size and Forecast (2017-2028)
8.3.5 India Pre-Menstrual Syndrome Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Pre-Menstrual Syndrome Market Size and Forecast (2017-2028)
8.3.7 Australia Pre-Menstrual Syndrome Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9 South America by Country, by Type, and by Application
9.1 South America Pre-Menstrual Syndrome Revenue by Type (2017-2028)
9.2 South America Pre-Menstrual Syndrome Revenue by Application (2017-2028)
9.3 South America Pre-Menstrual Syndrome Market Size by Country
9.3.1 South America Pre-Menstrual Syndrome Revenue by Country (2017-2028)
9.3.2 Brazil Pre-Menstrual Syndrome Market Size and Forecast (2017-2028)
9.3.3 Argentina Pre-Menstrual Syndrome Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Pre-Menstrual Syndrome Revenue by Type (2017-2028)
10.2 Middle East & Africa Pre-Menstrual Syndrome Revenue by Application (2017-2028)
10.3 Middle East & Africa Pre-Menstrual Syndrome Market Size by Country
10.3.1 Middle East & Africa Pre-Menstrual Syndrome Revenue by Country (2017-2028)
10.3.2 Turkey Pre-Menstrual Syndrome Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Pre-Menstrual Syndrome Market Size and Forecast (2017-2028)
10.3.4 UAE Pre-Menstrual Syndrome Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
11 Research Findings and Conclusion
12 Appendix
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Pre-Menstrual Syndrome Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Pre-Menstrual Syndrome Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Pre-Menstrual Syndrome Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Pre-Menstrual Syndrome Revenue (USD Million) by Region (2017-2022)
Table 5. Global Pre-Menstrual Syndrome Revenue Market Share by Region (2023-2028)
Table 6. Alva-Amco Pharmacal Cos., Inc. Corporate Information, Head Office, and Major Competitors
Table 7. Alva-Amco Pharmacal Cos., Inc. Major Business
Table 8. Alva-Amco Pharmacal Cos., Inc. Pre-Menstrual Syndrome Product and Solutions
Table 9. Alva-Amco Pharmacal Cos., Inc. Pre-Menstrual Syndrome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Bayer, Inc. Corporate Information, Head Office, and Major Competitors
Table 11. Bayer, Inc. Major Business
Table 12. Bayer, Inc. Pre-Menstrual Syndrome Product and Solutions
Table 13. Bayer, Inc. Pre-Menstrual Syndrome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Chattem, Inc. (Sanofi) Corporate Information, Head Office, and Major Competitors
Table 15. Chattem, Inc. (Sanofi) Major Business
Table 16. Chattem, Inc. (Sanofi) Pre-Menstrual Syndrome Product and Solutions
Table 17. Chattem, Inc. (Sanofi) Pre-Menstrual Syndrome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. DEKK-TEC, Inc. Corporate Information, Head Office, and Major Competitors
Table 19. DEKK-TEC, Inc. Major Business
Table 20. DEKK-TEC, Inc. Pre-Menstrual Syndrome Product and Solutions
Table 21. DEKK-TEC, Inc. Pre-Menstrual Syndrome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. G. R. Lane Health Products Ltd Corporate Information, Head Office, and Major Competitors
Table 23. G. R. Lane Health Products Ltd Major Business
Table 24. G. R. Lane Health Products Ltd Pre-Menstrual Syndrome Product and Solutions
Table 25. G. R. Lane Health Products Ltd Pre-Menstrual Syndrome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. McNeil Consumer Healthcare Corporate Information, Head Office, and Major Competitors
Table 27. McNeil Consumer Healthcare Major Business
Table 28. McNeil Consumer Healthcare Pre-Menstrual Syndrome Product and Solutions
Table 29. McNeil Consumer Healthcare Pre-Menstrual Syndrome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. MetP Pharma AG Corporate Information, Head Office, and Major Competitors
Table 31. MetP Pharma AG Major Business
Table 32. MetP Pharma AG Pre-Menstrual Syndrome Product and Solutions
Table 33. MetP Pharma AG Pre-Menstrual Syndrome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Pherin Pharmaceuticals, Inc. Corporate Information, Head Office, and Major Competitors
Table 35. Pherin Pharmaceuticals, Inc. Major Business
Table 36. Pherin Pharmaceuticals, Inc. Pre-Menstrual Syndrome Product and Solutions
Table 37. Pherin Pharmaceuticals, Inc. Pre-Menstrual Syndrome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Umecrine Mood AB Corporate Information, Head Office, and Major Competitors
Table 39. Umecrine Mood AB Major Business
Table 40. Umecrine Mood AB Pre-Menstrual Syndrome Product and Solutions
Table 41. Umecrine Mood AB Pre-Menstrual Syndrome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Novartis AG Corporate Information, Head Office, and Major Competitors
Table 43. Novartis AG Major Business
Table 44. Novartis AG Pre-Menstrual Syndrome Product and Solutions
Table 45. Novartis AG Pre-Menstrual Syndrome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. GlaxoSmithKline Plc Corporate Information, Head Office, and Major Competitors
Table 47. GlaxoSmithKline Plc Major Business
Table 48. GlaxoSmithKline Plc Pre-Menstrual Syndrome Product and Solutions
Table 49. GlaxoSmithKline Plc Pre-Menstrual Syndrome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Global Pre-Menstrual Syndrome Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 51. Global Pre-Menstrual Syndrome Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 52. Breakdown of Pre-Menstrual Syndrome by Company Type (Tier 1, Tier 2 and Tier 3)
Table 53. Pre-Menstrual Syndrome Players Head Office, Products and Services Provided
Table 54. Pre-Menstrual Syndrome Mergers & Acquisitions in the Past Five Years
Table 55. Pre-Menstrual Syndrome New Entrants and Expansion Plans
Table 56. Global Pre-Menstrual Syndrome Revenue (USD Million) by Type (2017-2022)
Table 57. Global Pre-Menstrual Syndrome Revenue Share by Type (2017-2022)
Table 58. Global Pre-Menstrual Syndrome Revenue Forecast by Type (2023-2028)
Table 59. Global Pre-Menstrual Syndrome Revenue by Application (2017-2022)
Table 60. Global Pre-Menstrual Syndrome Revenue Forecast by Application (2023-2028)
Table 61. North America Pre-Menstrual Syndrome Revenue by Type (2017-2022) & (USD Million)
Table 62. North America Pre-Menstrual Syndrome Revenue by Type (2023-2028) & (USD Million)
Table 63. North America Pre-Menstrual Syndrome Revenue by Application (2017-2022) & (USD Million)
Table 64. North America Pre-Menstrual Syndrome Revenue by Application (2023-2028) & (USD Million)
Table 65. North America Pre-Menstrual Syndrome Revenue by Country (2017-2022) & (USD Million)
Table 66. North America Pre-Menstrual Syndrome Revenue by Country (2023-2028) & (USD Million)
Table 67. Europe Pre-Menstrual Syndrome Revenue by Type (2017-2022) & (USD Million)
Table 68. Europe Pre-Menstrual Syndrome Revenue by Type (2023-2028) & (USD Million)
Table 69. Europe Pre-Menstrual Syndrome Revenue by Application (2017-2022) & (USD Million)
Table 70. Europe Pre-Menstrual Syndrome Revenue by Application (2023-2028) & (USD Million)
Table 71. Europe Pre-Menstrual Syndrome Revenue by Country (2017-2022) & (USD Million)
Table 72. Europe Pre-Menstrual Syndrome Revenue by Country (2023-2028) & (USD Million)
Table 73. Asia-Pacific Pre-Menstrual Syndrome Revenue by Type (2017-2022) & (USD Million)
Table 74. Asia-Pacific Pre-Menstrual Syndrome Revenue by Type (2023-2028) & (USD Million)
Table 75. Asia-Pacific Pre-Menstrual Syndrome Revenue by Application (2017-2022) & (USD Million)
Table 76. Asia-Pacific Pre-Menstrual Syndrome Revenue by Application (2023-2028) & (USD Million)
Table 77. Asia-Pacific Pre-Menstrual Syndrome Revenue by Region (2017-2022) & (USD Million)
Table 78. Asia-Pacific Pre-Menstrual Syndrome Revenue by Region (2023-2028) & (USD Million)
Table 79. South America Pre-Menstrual Syndrome Revenue by Type (2017-2022) & (USD Million)
Table 80. South America Pre-Menstrual Syndrome Revenue by Type (2023-2028) & (USD Million)
Table 81. South America Pre-Menstrual Syndrome Revenue by Application (2017-2022) & (USD Million)
Table 82. South America Pre-Menstrual Syndrome Revenue by Application (2023-2028) & (USD Million)
Table 83. South America Pre-Menstrual Syndrome Revenue by Country (2017-2022) & (USD Million)
Table 84. South America Pre-Menstrual Syndrome Revenue by Country (2023-2028) & (USD Million)
Table 85. Middle East & Africa Pre-Menstrual Syndrome Revenue by Type (2017-2022) & (USD Million)
Table 86. Middle East & Africa Pre-Menstrual Syndrome Revenue by Type (2023-2028) & (USD Million)
Table 87. Middle East & Africa Pre-Menstrual Syndrome Revenue by Application (2017-2022) & (USD Million)
Table 88. Middle East & Africa Pre-Menstrual Syndrome Revenue by Application (2023-2028) & (USD Million)
Table 89. Middle East & Africa Pre-Menstrual Syndrome Revenue by Country (2017-2022) & (USD Million)
Table 90. Middle East & Africa Pre-Menstrual Syndrome Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Pre-Menstrual Syndrome Picture
Figure 2. Global Pre-Menstrual Syndrome Revenue Market Share by Type in 2021
Figure 3. Analgesics (Pain Killers)
Figure 4. Oral Contraceptive Pills (OCPs)
Figure 5. Gonadotropin-Releasing Hormone (GnRH)
Figure 6. Antidepressants
Figure 7. Ovarian Suppressors
Figure 8. Diuretics
Figure 9. Benzodiazepines
Figure 10. Pre-Menstrual Syndrome Revenue Market Share by Application in 2021
Figure 11. Hospitals Picture
Figure 12. Clinic Picture
Figure 13. Others Picture
Figure 14. Global Pre-Menstrual Syndrome Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 15. Global Pre-Menstrual Syndrome Revenue and Forecast (2017-2028) & (USD Million)
Figure 16. Global Pre-Menstrual Syndrome Revenue Market Share by Region (2017-2028)
Figure 17. Global Pre-Menstrual Syndrome Revenue Market Share by Region in 2021
Figure 18. North America Pre-Menstrual Syndrome Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Europe Pre-Menstrual Syndrome Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Asia-Pacific Pre-Menstrual Syndrome Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. South America Pre-Menstrual Syndrome Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. Middle East and Africa Pre-Menstrual Syndrome Revenue (USD Million) and Growth Rate (2017-2028)
Figure 23. Pre-Menstrual Syndrome Market Drivers
Figure 24. Pre-Menstrual Syndrome Market Restraints
Figure 25. Pre-Menstrual Syndrome Market Trends
Figure 26. Alva-Amco Pharmacal Cos., Inc. Recent Developments and Future Plans
Figure 27. Bayer, Inc. Recent Developments and Future Plans
Figure 28. Chattem, Inc. (Sanofi) Recent Developments and Future Plans
Figure 29. DEKK-TEC, Inc. Recent Developments and Future Plans
Figure 30. G. R. Lane Health Products Ltd Recent Developments and Future Plans
Figure 31. McNeil Consumer Healthcare Recent Developments and Future Plans
Figure 32. MetP Pharma AG Recent Developments and Future Plans
Figure 33. Pherin Pharmaceuticals, Inc. Recent Developments and Future Plans
Figure 34. Umecrine Mood AB Recent Developments and Future Plans
Figure 35. Novartis AG Recent Developments and Future Plans
Figure 36. GlaxoSmithKline Plc Recent Developments and Future Plans
Figure 37. Global Pre-Menstrual Syndrome Revenue Share by Players in 2021
Figure 38. Pre-Menstrual Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 39. Global Top 3 Players Pre-Menstrual Syndrome Revenue Market Share in 2021
Figure 40. Global Top 10 Players Pre-Menstrual Syndrome Revenue Market Share in 2021
Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 42. Global Pre-Menstrual Syndrome Revenue Share by Type in 2021
Figure 43. Global Pre-Menstrual Syndrome Market Share Forecast by Type (2023-2028)
Figure 44. Global Pre-Menstrual Syndrome Revenue Share by Application in 2021
Figure 45. Global Pre-Menstrual Syndrome Market Share Forecast by Application (2023-2028)
Figure 46. North America Pre-Menstrual Syndrome Sales Market Share by Type (2017-2028)
Figure 47. North America Pre-Menstrual Syndrome Sales Market Share by Application (2017-2028)
Figure 48. North America Pre-Menstrual Syndrome Revenue Market Share by Country (2017-2028)
Figure 49. United States Pre-Menstrual Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Canada Pre-Menstrual Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Mexico Pre-Menstrual Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Europe Pre-Menstrual Syndrome Sales Market Share by Type (2017-2028)
Figure 53. Europe Pre-Menstrual Syndrome Sales Market Share by Application (2017-2028)
Figure 54. Europe Pre-Menstrual Syndrome Revenue Market Share by Country (2017-2028)
Figure 55. Germany Pre-Menstrual Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. France Pre-Menstrual Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. United Kingdom Pre-Menstrual Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Russia Pre-Menstrual Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Italy Pre-Menstrual Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Asia-Pacific Pre-Menstrual Syndrome Sales Market Share by Type (2017-2028)
Figure 61. Asia-Pacific Pre-Menstrual Syndrome Sales Market Share by Application (2017-2028)
Figure 62. Asia-Pacific Pre-Menstrual Syndrome Revenue Market Share by Region (2017-2028)
Figure 63. China Pre-Menstrual Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Japan Pre-Menstrual Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South Korea Pre-Menstrual Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. India Pre-Menstrual Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Southeast Asia Pre-Menstrual Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Australia Pre-Menstrual Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. South America Pre-Menstrual Syndrome Sales Market Share by Type (2017-2028)
Figure 70. South America Pre-Menstrual Syndrome Sales Market Share by Application (2017-2028)
Figure 71. South America Pre-Menstrual Syndrome Revenue Market Share by Country (2017-2028)
Figure 72. Brazil Pre-Menstrual Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Argentina Pre-Menstrual Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Middle East and Africa Pre-Menstrual Syndrome Sales Market Share by Type (2017-2028)
Figure 75. Middle East and Africa Pre-Menstrual Syndrome Sales Market Share by Application (2017-2028)
Figure 76. Middle East and Africa Pre-Menstrual Syndrome Revenue Market Share by Country (2017-2028)
Figure 77. Turkey Pre-Menstrual Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Pre-Menstrual Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. UAE Pre-Menstrual Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Methodology
Figure 81. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
